Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology Basel, Switzerland / Zurich-Schlieren, Switzerland, 04 December 2013. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Molecular Partners AG today announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics [...]
Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy Deal brings Blackhawk’s retail network to over 40,000 retail locations in world’s 4th largest economy LONDON – Dec. 2, 2013 – Blackhawk Network announced that it has completed the acquisition of Germany-based Retailo AG, [...]
ECUBLENS, SWITZERLAND – Oct. 28, 2013 – Symetis Inc., a privately-owned Swiss company focused on transcatheter aortic valve implantation (TAVI) systems announced today that it has achieved a symbolic milestone: the implantation of the 1000th ACURATE TA™ transaortic valve. The first ACURATE TA™ valve was implanted in November 2009 [...]
Former Worldwide VP for Regulatory Affairs at Johnson & Johnson Brings Vast Experience in Medical Device Submissions, Approvals and GMP Compliance. MONTREUX, Switzerland, April 13, 2010 – CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2 diabetes, [...]
CAMBRIDGE, Mass. (EON: Enhanced Online News) BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, announced today the pricing of its initial public offering of 4,700,000 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts [...]